Related Experiment Videos
ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner
Zhiyong Ren1, Timothy S Schaefer
1Department of Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
Stats (signal transducer and activator of transcription) are latent transcription factors that translocate from the cytoplasm to the nucleus. Constitutive activation of Stat3 alpha by upstream oncoproteins and receptor tyrosine kinases has been found in many human tumors and tumor-derived cell lines. Constitutively activated Stat3 alpha is often correlated with the activation of ErbB-2, a member of the EGFR family. To explore the involvement of ErbB-2 in the activation of Stat3 and the mechanism underlying this event, an ErbB-2 point mutant was used as a model of constitutively activated receptor. Phenylalanine mutations (Y-->F) were made in the autophosphorylation sites of the receptor, and their ability to activate Stat3 alpha was evaluated. Our results suggest that Stat3 alpha and JAK2 associates with ErbB-2 prior to phosphorylation of the receptor and that full activation of Stat3 alpha by ErbB-2 requires the participation of other non-receptor tyrosine kinases. Both Src and Jak2 kinases contribute to the activation of Stat3 alpha but Src binds to ErbB-2 only when the receptor is phosphorylated. Our results also suggest that tyrosine 1139 may be important for Src homology 2 domain association because a mutant lacking this tyrosine reduces the ability of the Src homology 2 domain to bind to ErbB-2 and significantly decreases its ability to activate Stat3 alpha.
Insights
Signal transducer and activator of transcription 3 (Stat3) activation in cancer involves ErbB-2. This study reveals that JAK2 and Src kinases mediate Stat3 activation by ErbB-2, clarifying a key cancer signaling pathway.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- Signal transducer and activator of transcription (Stat) proteins are key transcription factors.
- Constitutive activation of Stat3 alpha is observed in many human cancers.
- Stat3 activation is often linked to ErbB-2, a receptor tyrosine kinase.
Purpose of the Study:
- To investigate the role of ErbB-2 in Stat3 activation.
- To elucidate the molecular mechanisms underlying ErbB-2-mediated Stat3 activation.
Main Methods:
- Utilized a constitutively activated ErbB-2 point mutant (Y-->F) at autophosphorylation sites.
- Assessed the activation of Stat3 alpha in response to the ErbB-2 mutant.
- Investigated the involvement of JAK2 and Src kinases in the activation pathway.
Main Results:
- Stat3 alpha and JAK2 associate with ErbB-2 before receptor phosphorylation.
- Full Stat3 alpha activation by ErbB-2 requires non-receptor tyrosine kinases like Src and JAK2.
- Src binds to phosphorylated ErbB-2, and tyrosine 1139 is crucial for Src binding and Stat3 activation.
Conclusions:
- ErbB-2 signaling pathways involve JAK2 and Src kinases in Stat3 activation.
- Tyrosine 1139 on ErbB-2 plays a critical role in mediating Src binding and subsequent Stat3 activation.
- Understanding this mechanism provides insights into targeted cancer therapies.